Cary Street Partners Investment Advisory LLC Immuneering Corp Transaction History

Cary Street Partners Investment Advisory LLC

$2.33 Billion
Q1 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 12, 2023	BUY	$3.78 - $10.38 $1,137 - $3,124	301 New	301 $2,000

Others Institutions Holding IMRX

# of Institutions

Shares Held

11.6M

Call Options Held

Put Options Held

Cormorant Asset Management, LP Boston, MA

3.3M
Shares

$4.22 Million
0.55% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

1.88M
Shares

$2.41 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.38M
Shares

$1.76 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.54 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

910K
Shares

$1.17 Million
0.0% of portfolio

View Full List

About Immuneering Corp

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $33.8M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

More about IMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account